Partners
Intelligencia AI was founded in 2017 to address the rising costs, extended timelines, and shrinking ROI in the $1.5 trillion pharmaceutical industry. We support biopharma in de-risking & streamlining drug development by applying the latest AI-based innovations and utilizing the billions of medical and scientific data points to improve the predictive power of probability of success. Our team’s expertise in data science, clinical data, and business drives drug development forward. We’re passionate about enabling biopharmaceutical companies to enhance efficiency – not just from a clinical development and business growth perspective – but to influence the ability to bring novel treatments to patients, faster.
Planisware is a leading business-to-business (“B2B”) provider of Software-as-a-Service (“SaaS”) in the rapidly growing Project Economy. Planisware’s mission is to provide solutions that help organizations transform how they strategize, plan and deliver their projects, project portfolios, programs and products.
With close to 700 employees across 12 offices, Planisware operates at significant scale serving around 550 organizational clients in a wide range of verticals and functions across more than 30 countries worldwide. Planisware’s clients include large international companies, medium-sized businesses and public sector entities. For more information, visit: www.planisware.com
Connect with Planisware on LinkedIn and X (formerly Twitter).
